December 20, 2024
December 2024 OSUCCC – James Grants, Awards and Honors
The OSUCCC – James announces awards, honors, grants and more that were recently given to the organization, teams or individuals in December 2024.
News & Media
Showing 1-10 of 34
October 10, 2024
Study shows key role of genetics in identifying ancestry-based aspects of cancer, survival
Researchers at the OSUCCC – James led a global study that identified molecular predictors of survival among Black patients with acute myeloid leukemia (AML). The study suggests a need to modify current AML risk layers by including ancestry-specific genetic factors and testing those in clinical trials.
June 21, 2024
June 2024 OSUCCC James Grants, Awards and Honors
The OSUCCC – James announces the following awards, honors, grants and more that were recently given to the organization, teams or individuals.
January 23, 2024
January 2024 OSUCCC – James Grants, Awards and Honors
The OSUCCC - James announces the following awards, honors, grants and more that were recently given to the organization, teams or individuals.
October 24, 2023
Two NCI grants will support innovative studies of acute myeloid leukemia
Two five-year grants totaling more than $6 million from the National Cancer Institute will help The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute researchers and colleagues at other institutions better understand acute myeloid leukemia genetics and the role of inflammation in regulating immune response to this disease.
January 11, 2023
2022 OSUCCC - James Team and Individual Awards and Achievements
A compilation of team and individual awards and achievements at OSUCCC - James in 2022.
January 10, 2023
2022 Ohio State Cancer Research and Grant Highlights
A compilation of research and grants conducted at OSUCCC - James in 2022.
December 17, 2020
Ohio State Announces Passing of Scientist Dr. Albert de la Chapelle
With great sadness, the OSUCCC – James announces the passing of Albert de la Chapelle, MD, PhD, a Distinguished University Professor in the Ohio State College of Medicine, Department of Cancer Biology and Genetics. Dr. de la Chapelle died Thursday, Dec. 10, at age 87.
December 4, 2020
Study: Young Black Patients With AML Have Worse Treatment Outcomes
Despite advances in treating acute myeloid leukemia (AML), younger Black patients, below the age of 60, with this aggressive blood cancer have a 27% higher chance of dying compared with younger white patients. OSUCCC – James researchers report new data.
November 23, 2020
Ohio State Creates Clara D. Bloomfield Center for Leukemia Outcomes Research
The OSUCCC – James has established a new center dedicated to maintaining and expanding the legacy of the late Clara D. Bloomfield, MD. The center will be initially supported by a $5 million commitment from the OSUCCC – James.